Henry Schein, Inc. (NASDAQ:HSIC) Given Consensus Rating of “Moderate Buy” by Brokerages

Henry Schein, Inc. (NASDAQ:HSICGet Free Report) has been assigned a consensus rating of “Moderate Buy” from the eleven ratings firms that are covering the stock, Marketbeat reports. Six analysts have rated the stock with a hold recommendation, four have assigned a buy recommendation and one has given a strong buy recommendation to the company. The average twelve-month price target among brokerages that have updated their coverage on the stock in the last year is $78.89.

HSIC has been the topic of a number of recent analyst reports. StockNews.com raised shares of Henry Schein from a “sell” rating to a “hold” rating in a research note on Thursday, November 7th. Evercore ISI boosted their price target on Henry Schein from $70.00 to $74.00 and gave the stock an “in-line” rating in a report on Tuesday, October 8th. Barrington Research restated an “outperform” rating and set a $82.00 price objective on shares of Henry Schein in a research report on Wednesday, November 6th. Finally, Mizuho initiated coverage on Henry Schein in a research report on Wednesday, December 4th. They issued a “neutral” rating and a $75.00 target price on the stock.

Read Our Latest Stock Analysis on HSIC

Insider Transactions at Henry Schein

In other news, COO Michael S. Ettinger sold 12,240 shares of Henry Schein stock in a transaction on Monday, November 18th. The shares were sold at an average price of $75.00, for a total transaction of $918,000.00. Following the transaction, the chief operating officer now owns 87,706 shares in the company, valued at approximately $6,577,950. The trade was a 12.25 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 1.14% of the company’s stock.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the stock. Cromwell Holdings LLC increased its stake in shares of Henry Schein by 93.4% in the third quarter. Cromwell Holdings LLC now owns 352 shares of the company’s stock valued at $26,000 after buying an additional 170 shares during the period. Summit Securities Group LLC acquired a new stake in Henry Schein during the 2nd quarter valued at approximately $31,000. Blue Trust Inc. raised its holdings in Henry Schein by 104.2% during the 2nd quarter. Blue Trust Inc. now owns 931 shares of the company’s stock worth $60,000 after purchasing an additional 475 shares during the last quarter. Farther Finance Advisors LLC raised its holdings in Henry Schein by 58.9% during the 3rd quarter. Farther Finance Advisors LLC now owns 933 shares of the company’s stock worth $68,000 after purchasing an additional 346 shares during the last quarter. Finally, Livforsakringsbolaget Skandia Omsesidigt lifted its position in shares of Henry Schein by 282.1% in the 3rd quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,490 shares of the company’s stock worth $109,000 after purchasing an additional 1,100 shares during the period. 96.62% of the stock is owned by institutional investors.

Henry Schein Stock Performance

NASDAQ:HSIC opened at $69.82 on Tuesday. The company has a market cap of $8.71 billion, a price-to-earnings ratio of 28.73, a PEG ratio of 2.31 and a beta of 0.87. Henry Schein has a fifty-two week low of $63.67 and a fifty-two week high of $82.63. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. The stock has a fifty day moving average price of $72.39 and a 200-day moving average price of $70.13.

Henry Schein (NASDAQ:HSICGet Free Report) last posted its quarterly earnings data on Tuesday, November 5th. The company reported $1.22 earnings per share for the quarter, topping the consensus estimate of $1.17 by $0.05. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The business had revenue of $3.17 billion during the quarter, compared to analysts’ expectations of $3.24 billion. During the same quarter in the prior year, the business posted $1.32 earnings per share. Henry Schein’s revenue was up .4% compared to the same quarter last year. As a group, equities analysts anticipate that Henry Schein will post 4.78 EPS for the current fiscal year.

Henry Schein Company Profile

(Get Free Report

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Read More

Analyst Recommendations for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.